Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.30 |
| ▸ | LTA4H | P09960 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9582838 | 0.82 | CYP3A4 (0.38) | KDM4EALDH1A1HPGDCYP3A4TDP1 | |
| Hydrochloric Acid SCHEMBL9582409 | 0.81 | CYP3A4 (0.41) | KDM4EALDH1A1HPGDCYP3A4TDP1 | |
| SCHEMBL8945781 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL8945916 | 0.76 | CYP3A4 (0.30) | CYP3A4TDP1 | |
| SCHEMBL9583335 | 0.76 | CYP2D6 (0.35) | KDM4EALDH1A1HPGDCYP3A4 | |
| SCHEMBL8945887 | 0.75 | IDO1 (0.36) | CYP3A4 | |
| Hydrochloric Acid SCHEMBL9582500 | 0.75 | CYP2D6 (0.34) | KDM4EALDH1A1CYP3A4 | |
| SCHEMBL8946017 | 0.74 | ALOX5 (0.33) | KDM4EALDH1A1HPGDCYP3A4TDP1 | |
| SCHEMBL9001661 | 0.73 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL8946115 | 0.73 | SLC6A2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5510346-A | ANTIDEPRESSANTS, ANTIANXIETY AGENTS | HOECHST MARION ROUSSEL, INC. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5292760-A | 4-heteroaryl-1,3-benzodiazepines and 2-substituted-α-(heteroaryl)benzeneethanamines | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1994-03-08 | — | — | US | disclosed |
| EP-0322582-A2 | 4-Heteroaryl-1,3-Benzodiazepines and 2-substituted-alpha-(heteroaryl)benzeneethanamines, a process for their preparation and their use us medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-07-05 | — | — | EP | disclosed |